Search...
⌘K

Modified Early Warning Score (MEWS) for Clinical Deterioration
MEWS
Detects early clinical deterioration in hospitalized patients

Modified Early Warning Score (MEWS) for Clinical Deterioration
MEWS
Detects early clinical deterioration in hospitalized patients
Instructions
The MEWS tool is used to monitor patients’ vital signs and identify early clinical deterioration. Record heart rate, blood pressure, respiratory rate, temperature, and level of consciousness. Assign a score for each parameter and add them for the total MEWS.
Overview
When to use
Why use
Evidences
Interpretation
MEWS Score | Interpretation |
0–2 | Low risk: routine monitoring |
3–4 | Moderate risk: increased monitoring, consider clinical review |
5 or more | High risk: urgent clinical review, possible ICU transfer |
Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified Early Warning Score in medical admissions. QJM. 2001;94(10):521–526. Introduced and validated the Modified Early Warning Score (MEWS) in acute medical patients; higher MEWS associated with increased ICU admission and mortality; MEWS ≥5 identified patients at higher risk of adverse outcomes.
https://academic.oup.com/qjmed/article-abstract/94/10/521/1558977?redirectedFrom=fulltext&login=false
Gao H, McDonnell A, Harrison DA, et al. Systematic review and evaluation of physiological track and trigger warning systems for identifying at-risk patients on the ward. Intensive Care Med. 2007;33(4):667–679. Early systematic review showing EWS (including MEWS) associated with earlier recognition and potential reduction in cardiac arrest rates when embedded in response systems. https://link.springer.com/article/10.1007/s00134-007-0532-3
Overview
When to use
Why use
Evidences
The Modified Early Warning Score (MEWS) is a clinical scoring system designed to detect early signs of patient deterioration and guide timely interventions. It was developed to support decision-making in general hospital wards by using vital sign abnormalities to predict the risk of adverse outcomes such as cardiac arrest, unplanned intensive care admission, or death.
MEWS evaluates five key parameters: systolic blood pressure, heart rate, respiratory rate, temperature, and level of consciousness (AVPU: Alert, Voice, Pain, Unresponsive). Each parameter is scored from 0 to 3 depending on how far it deviates from the normal range. The scores are summed, yielding a total MEWS that can range from 0 upward, with higher scores reflecting greater physiological instability.
The main strength of MEWS lies in its simplicity and clinical utility. It allows healthcare providers, including nurses and junior doctors, to quickly recognize changes in patient status. Evidence suggests that routine monitoring using MEWS can reduce delays in escalation of care and improve patient outcomes. It also provides an objective way to trigger rapid response team activation or more frequent monitoring, depending on hospital protocols.
Overview
When to use
Why use
Evidences
Interpretation
MEWS Score | Interpretation |
0–2 | Low risk: routine monitoring |
3–4 | Moderate risk: increased monitoring, consider clinical review |
5 or more | High risk: urgent clinical review, possible ICU transfer |
Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified Early Warning Score in medical admissions. QJM. 2001;94(10):521–526. Introduced and validated the Modified Early Warning Score (MEWS) in acute medical patients; higher MEWS associated with increased ICU admission and mortality; MEWS ≥5 identified patients at higher risk of adverse outcomes.
https://academic.oup.com/qjmed/article-abstract/94/10/521/1558977?redirectedFrom=fulltext&login=false
Gao H, McDonnell A, Harrison DA, et al. Systematic review and evaluation of physiological track and trigger warning systems for identifying at-risk patients on the ward. Intensive Care Med. 2007;33(4):667–679. Early systematic review showing EWS (including MEWS) associated with earlier recognition and potential reduction in cardiac arrest rates when embedded in response systems. https://link.springer.com/article/10.1007/s00134-007-0532-3
Frequently Asked Questions
Features and Services FAQs
Discover the full range of features and services we offer and how to use them.
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
Ready to Transform Your Practice?
Join thousands of clinicians saving hours daily with AI-powered documentation.
14-day free trial • No setup fees
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.
DocScrib
AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.
Model for End-Stage Liver Disease (Combined MELD)